Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact

Citations to this article

Natural anticoagulant mechanisms.
R D Rosenberg, J S Rosenberg
R D Rosenberg, J S Rosenberg
Published July 1, 1984
Citation Information: J Clin Invest. 1984;74(1):1-6. https://doi.org/10.1172/JCI111389.
View: Text | PDF
Research Article Article has an altmetric score of 3

Natural anticoagulant mechanisms.

  • Text
  • PDF
Abstract

Authors

R D Rosenberg, J S Rosenberg

×

Total citations by year

Year: 2024 2023 2022 2021 2020 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2004 2003 2002 2001 2000 1999 1998 1997 1996 1995 1994 1993 1992 1991 1990 1989 1988 1987 1986 1985 Total
Citations: 1 2 4 1 3 1 3 1 3 3 1 5 4 2 3 4 2 4 1 7 3 1 6 6 11 7 7 2 9 9 9 7 7 14 9 10 14 4 190
Citation information
This citation data is accumulated from CrossRef, which receives citation information from participating publishers, including this journal. Not all publishers participate in CrossRef, so this information is not comprehensive. Additionally, data may not reflect the most current citations to this article, and the data may differ from citation information available from other sources (for example, Google Scholar, Web of Science, and Scopus).

Citations to this article (190)

Title and authors Publication Year
Electrochemical Monitoring in Anticoagulation Therapy.
Mruthunjaya AKV, Torriero AAJ
Molecules (Basel, Switzerland) 2024
Investigating protein C and S levels in pregnant women with recurrent early pregnancy loss versus normal pregnancy.
Mukhtar B, Garg R, Ibrahim G, Batra J
Journal of medicine and life 2023
CROSS-TALK BETWEEN THE PLASMINOGEN/PLASMIN SYSTEM AND INFLAMMATION RESOLUTION: Pro-resolving properties of the Plg/Pla system
Perucci LO, Vago JP, Miles LA, Sousa LP
Journal of Thrombosis and Haemostasis 2023
Coagulation and complement: Key innate defense participants in a seamless web
Pryzdial EL, Leatherdale A, Conway EM
Frontiers in immunology 2022
Native and activated antithrombin inhibits TMPRSS2 activity and SARS-CoV-2 infection.
Wettstein L, Immenschuh P, Weil T, Conzelmann C, Almeida-Hernández Y, Hoffmann M, Kempf A, Nehlmeier I, Lotke R, Petersen M, Stenger S, Kirchhoff F, Sauter D, Pöhlmann S, Sanchez-Garcia E, Münch J
Journal of Medical Virology 2022
Anticoagulants: A Short History, Their Mechanism of Action, Pharmacology, and Indications.
Heestermans M, Poenou G, Hamzeh-Cognasse H, Cognasse F, Bertoletti L
Cells 2022
Factor IX(a) inhibitors: an updated patent review (2003-present).
Afosah DK, Ofori E, Mottamal M, Al-Horani RA
Expert Opinion on Therapeutic Patents 2022
Human endothelial cells and fibroblasts express and produce the coagulation proteins necessary for thrombin generation
CT Cohen, NA Turner, JL Moake
Scientific Reports 2021
Recombinant human soluble thrombomodulin is associated with attenuation of sepsis-induced renal impairment by inhibition of extracellular histone release
M Akatsuka, Y Masuda, H Tatsumi, M Yamakage, P Mukhopadhyay
PloS one 2020
Therapeutic strategies for thrombosis: new targets and approaches
N Mackman, W Bergmeier, GA Stouffer, JI Weitz
Nature Reviews Drug Discovery 2020
Heme oxygenase-1 modulation: A potential therapeutic target for COVID-19 and associated complications
D Singh, H Wasan, KH Reeta
Free radical biology & medicine 2020
Antithrombotic potential of esculin 7, 3′, 4′, 5′, 6′-O-pentasulfate (EPS) for its role in thrombus reduction using rat thrombosis model
I Ahmad, S Sharma, N Gupta, Q Rashid, M Abid, MZ Ashraf, MA Jairajpuri
International Journal of Biological Macromolecules 2018
Factor V has an anticoagulant cofactor activity that targets the early phase of coagulation
S Santamaria, N Reglińska-Matveyev, M Gierula, RM Camire, JT Crawley, DA Lane, J Ahnström
The Journal of biological chemistry 2017
Optical sensing of anticoagulation status: Towards point-of-care coagulation testing
DM Tshikudi, MM Tripathi, Z Hajjarian, EM van Cott, SK Nadkarni, T Abraham
PloS one 2017
Sudden Cardiac Death
RJ Myerburg
Cardiac Electrophysiology Clinics 2017
Reaction Mechanisms and Kinetic Constants used in Mechanistic Models of Coagulation and Fibrinolysis
AM Susree, BM Anand, G Bocharov, J Clairambault, V Volpert
Mathematical Modelling of Natural Phenomena 2016
Heparins in ulcerative colitis: proposed mechanisms of action and potential reasons for inconsistent clinical outcomes
QY Lean, N Gueven, RD Eri, R Bhatia, SS Sohal, N Stewart, GM Peterson, RP Patel
Expert Review of Clinical Pharmacology 2015
Polysulfated Trehalose as a Novel Anticoagulant Agent with Dual Mode of Action
Q Rashid, M Abid, N Gupta, T Tyagi, MZ Ashraf, MA Jairajpuri
BioMed Research International 2015
A Novel Interaction between Complement Inhibitor C4b-binding Protein and Plasminogen That Enhances Plasminogen Activation
V Agarwal, S Talens, AM Grandits, AM Blom
The Journal of biological chemistry 2015
Macromolecular Approaches to Prevent Thrombosis and Intimal Hyperplasia Following Percutaneous Coronary Intervention
RA Scott, A Panitch
Biomacromolecules 2014
The hyperglycemic byproduct methylglyoxal impairs anticoagulant activity through covalent adduction of antithrombin III
R Jacobson, N Mignemi, K Rose, L O’Rear, S Sarilla, HE Hamm, JV Barnett, IM Verhamme, J Schoenecker
Thrombosis Research 2014
Structure and function of antithrombin
N AKITA, K SUZUKI, T HAYASHI
Japanese Journal of Thrombosis and Hemostasis 2014
Heme Oxygenase 1 Modulates Thrombomodulin and Endothelial Protein C Receptor Levels to Attenuate Septic Kidney Injury:
K Kang, C Nan, D Fei, X Meng, W Liu, W Zhang, L Jiang, M Zhao, S Pan, M Zhao
Shock 2013
The C-terminal fragment of axon guidance molecule Slit3 binds heparin and neutralizes heparin's anticoagulant activity
E Condac, H Strachan, G Gutierrez-Sanchez, B Brainard, C Giese, C Heiss, D Johnson, P Azadi, C Bergmann, R Orlando, CT Esmon, J Harenberg, K Moremen, L Wang
Glycobiology 2012
Methods in Enzymology
JD Stone, AS Chervin, DH Aggen, DM Kranz
Protein Engineering for Therapeutics Part B 2012
Antithrombotic effect of a novel protein from <i>Fusarium</i> sp. CPCC 480097 in a rat model of artery-vein bypass thrombosis
B Wu, J Xu
Pharmaceutical Biology 2012
Pathogenic and Diagnostic Potential of BLCA-1 and BLCA-4 Nuclear Proteins in Urothelial Cell Carcinoma of Human Bladder
M Santoni, F Catanzariti, D Minardi, L Burattini, M Nabissi, G Muzzonigro, S Cascinu, G Santoni
Advances in Urology 2012
Applied Physiology in Intensive Care Medicine 2
MR Pinsky, L Brochard, J Mancebo, M Antonelli
2012
Thrombin and vascular inflammation
M Popović, K Smiljanić, B Dobutović, T Syrovets, T Simmet, ER Isenović
Molecular and Cellular Biochemistry 2011
Human cytomegalovirus infection and atherothrombosis
M Popović, K Smiljanić, B Dobutović, T Syrovets, T Simmet, ER Isenović
Journal of Thrombosis and Thrombolysis 2011
Aurintricarboxylic acid inhibits the nuclear factor-κB-dependent expression of intercellular cell adhesion molecule-1 and endothelial cell selectin on activated human endothelial cells
JE Kim, S Lee, KS Han, HK Kim
Blood Coagulation & Fibrinolysis 2011
Endotheliopathy
Y Ouellette, JA Hazelzet
Pediatric Critical Care 2011
The endothelium: physiological functions and role in microcirculatory failure during severe sepsis
H Ait-Oufella, E Maury, S Lehoux, B Guidet, G Offenstadt
Intensive Care Medicine 2010
Ashcraft's Pediatric Surgery
KA Neville, BM Wicklund, GM Woods
Ashcraft's Pediatric Surgery 2010
Soluble Thrombomodulin Protects Ischemic Kidneys
AA Sharfuddin, RM Sandoval, DT Berg, GE McDougal, SB Campos, CL Phillips, BE Jones, A Gupta, BW Grinnell, BA Molitoris
Journal of the American Society of Nephrology : JASN 2009
Regulation of thrombin generation by TFPI in plasma without and with heparin
E Brodin, H Appelbom, B Østerud, I Hilden, LC Petersen, JB Hansen
Translational Research 2009
Management of Acute Kidney Problems
A Jörres, C Ronco, JA Kellum
2009
Annexin A2: biology and relevance to the antiphospholipid syndrome
E Cockrell, RG Espinola, KR McCrae
Lupus 2008
Low molecular weight dextran sulfate as complement inhibitor and cytoprotectant in solid organ and islet transplantation
R Spirig, T Gajanayake, O Korsgren, B Nilsson, R Rieben
Molecular Immunology 2008
The Yin–Yang of thrombin and activated protein C
T Dutt, CH Toh
British Journal of Haematology 2008
Decreased activated protein C levels as a clinical predictor in patients with ST-elevation myocardial infarction
N Chiba, K Nagao, T Mukoyama, Y Tominaga, K Tanjoh
American Heart Journal 2008
Sulfated polysaccharide purified from Ecklonia cava accelerates antithrombin III-mediated plasma proteinase inhibition
WK Jung, Y Athukorala, YJ Lee, SH Cha, CH Lee, T Vasanthan, KS Choi, SH Yoo, SK Kim, YJ Jeon
Journal of Applied Phycology 2007
Vasculite cutânea de pequenos vasos: etiologia, patogênese, classificação e critérios diagnósticos - Parte I
HR Brandt, M Arnone, NY Valente, PR Criado, MN Sotto
Anais Brasileiros de Dermatologia 2007
Membrane–mimetic films containing thrombomodulin and heparin inhibit tissue factor-induced thrombin generation in a flow model
PY Tseng, SS Rele, XL Sun, EL Chaikof
Biomaterials 2006
Endothelial cell protection in xenotransplantation: looking after a key player in rejection
Y Banz, R Rieben
Xenotransplantation 2006
Hemostasis, Surgical Bleeding, and Transfusion
BL Schaer
Equine Surgery 2006
Perioperative Fluid Therapy
J Boldt
Perioperative Fluid Therapy 2006
Oral Direct Thrombin Inhibition: an Effective and Novel Approach for Venous Thromboembolism
S Haas
Drugs 2004
Low tissue factor pathway inhibitor (TFPI) together with low antithrombin allows sufficient thrombin generation in neonates
G Cvirn, S Gallistl, B Leschnik, W Muntean
Journal of Thrombosis and Haemostasis 2003
Thyrotropin Stimulates Production of Procoagulant and Vasodilatative Factors in Human Aortic Endothelial Cells
D Donnini, FS Ambesi-Impiombato, F Curcio
Thyroid 2003
Selective Factor Xa Inhibition Improves Efficacy of Venous Thromboembolism Prophylaxis in Orthopedic Surgery
PC Comp
Pharmacotherapy 2003
Fluid Therapy and Coagulation
MF James
Transfusion Alternatives in Transfusion Medicine 2003
Prolonged bleeding time induced by anticoagulant glycosaminoglycans in dogs is associated with the inhibition of thrombin-induced platelet aggregation
K Kitazato, KT Kitazato, E Sasaki, K Minamiguchi, H Nagase
Thrombosis Research 2003
A Brief Historical Review of the Waterfall/Cascade of Blood Coagulation
EW Davie
The Journal of biological chemistry 2003
Child witnesses to domestic violence: A meta-analytic review
KM Kitzmann, NK Gaylord, AR Holt, ED Kenny
Journal of Consulting and Clinical Psychology 2003
Fondaparinux, a Synthetic Pentasaccharide: The First in a New Class of Antithrombotic Agents - The Selective Factor Xa Inhibitors
KA Bauer, DW Hawkins, PC Peters, M Petitou, JM Herbert, CA Boeckel, DG Meuleman
Cardiovascular Drug Reviews 2002
Arterial Blood Flow and Microcirculatory Changes in a Rat Groin Flap after Thrombosis Induced by Electrical Stimulation of the Artery
Y Qi, B Gazelius, B Linderoth, T Lundeberg
Microvascular Research 2002
Pan Vascular Medicine
P Lanzer, EJ Topol
2002
The N-terminal Epidermal Growth Factor-like Domain in Factor IX and Factor X Represents an Important Recognition Motif for Binding to Tissue Factor
D Zhong, MS Bajaj, AE Schmidt, SP Bajaj
The Journal of biological chemistry 2001
A new model of human aortic endothelial cells in vitro
D Donnini, G Perrella, G Stel, FS Ambesi-Impiombato, F Curcio
Biochimie 2000
Antithrombotic and prothrombotic activities of the vascular endothelium
A Sagripanti, A Carpi
Biomedecine & Pharmacotherapy 2000
Thrombin and Factor Xa Enhance Neutrophil Chemoattractant Production after Ischemia/Reperfusion in the Rat Liver
Y Yamaguchi, K Okabe, J Liang, H Ohshiro, K Ishihara, S Uchino, JL Zhang, H Hidaka, S Yamada, M Ogawa
Journal of Surgical Research 2000
High Affinity Binding of β 2 -Glycoprotein I to Human Endothelial Cells Is Mediated by Annexin II
K Ma, R Simantov, JC Zhang, R Silverstein, KA Hajjar, KR McCrae
The Journal of biological chemistry 2000
Estudo experimental do uso de um antagonista do receptor da glicoproteína IIb/IIIa das placentas na prevenção de tromboses em microanastomoses vasculares
MI Oide
Acta Ortopédica Brasileira 2000
Changes of Hemostatic Molecular Markers After Gynecological Surgery
K Noda, H Wada, N Yamada, N Noda, EC Gabazza, K Kumeda, T Okugawa, K Yanoh, M Ito, T Nakano, H Shiku, T Nobori, H Kato, N Toyoda
Clinical and Applied Thrombosis/Hemostasis 2000
Blood Coagulation
KG Mann
Alcoholism, clinical and experimental research 1999
Platelet-dependent and procoagulant mechanisms in arterial thrombosis
PR Eisenberg, G Ghigliotti
International Journal of Cardiology 1999
NEUTROPHIL ELASTASE AND OXYGEN RADICALS ENHANCE MONOCYTE CHEMOATTRACTANT PROTEIN-1 EXPRESSION AFTER ISCHEMIA/REPERFUSION IN RAT LIVER:
Y Yamaguchi, F Matsumura, J Liang, K Okabe, H Ohshiro, K Ishihara, T Matsuda, K Mori, M Ogawa
Transplantation 1999
Antithrombotics
AC Uprichard, KP Gallagher
1999
Screening for Aetiology of Thrombophilia: A High Prevalence of Protein S Abnormality
H Tsuda, S Hattori, S Tanabe, H Iida, M Nakahara, S Nishioka, M Fujise, S Kinoshita, K Okubo, N Hamasaki
Annals of Clinical Biochemistry 1999
A synthetic selective inhibitor of factor Xa, DX-9065a, reduces monocyte chemoattractant protein-1 expression after ischemia-reperfusion injury in rat liver
Y Yamaguchi, K Okabe, J Liang, F Matsumura, H Ohshiro, K Ishihara, T Matsuda, M Takeya, J I Kuratsu, K Mori, S Yamada, M Ogawa
Digestive Diseases and Sciences 1999
Synthetic and recombinant antithrombin drugs
B Kaiser, D Callas, JM Walenga, J Fareed
Expert Opinion on Investigational Drugs 1998
Recombinant TFPI and variants:potential implications in the treatment of cardiovascular disorders
B Kaiser, DH Hoppensteadt, J Fareed
Expert Opinion on Investigational Drugs 1998
Hypotension and inflammatory cytokine gene expression triggered by factor Xa-nitric oxide signaling
A Papapetropoulos, P Piccardoni, G Cirino, M Bucci, R Sorrentino, C Cicala, K Johnson, V Zachariou, WC Sessa, DC Altieri
Proceedings of the National Academy of Sciences 1998
Human endothelial cells do not exert heparin like accelerating effects on thrombin-antithrombin-complex formation
K Ruzicka, J Wojta, O Artemiou, T Birsan, P Quehenberger, S Kapiotis, R Hofbauer, W Speiser
Life Sciences 1998
The Antithrombotic Effect of Potent Bifunctional Thrombin Inhibitors Based on Hirudin Sequence, P551 and P532, on He-Ne Laser-Induced Thrombosis in Rat Mesenteric Microvessels
T Yamashita, Y Tsuda, Y Konishi, Y Okada, A Matsuoka, JC Giddings, J Yamamoto
Thrombosis Research 1998
Cutaneous small-vessel vasculitis
T Lotti, I Ghersetich, C Comacchi, JL Jorizzo
Journal of the American Academy of Dermatology 1998
The Human Complement System in Health and Disease
J Ahearn, A Rosengard
The Human Complement System in Health and Disease 1998
Platelets and cardiopulmonary bypass
JA Hyde, JA Chinn, TR Graham
Perfusion 1998
Monocyte chemoattractant protein-1 enhances expression of intercellular adhesion molecule-1 following ischemia-reperfusion of the liver in rats
Y Yamaguchi, F Matsumura, M Takeya, O Ichiguchi, JI Kuratsu, T Horiuchi, E Akizuki, T Matsuda, K Okabe, H Ohshiro, J Liang, K Mori, S Yamada, K Takahashi, M Ogawa
Hepatology 1998
Decreased Fibrinolytic Activity in Porcine-to-Primate Cardiac Xenotransplantation
MF Kalady, JH Lawson, RD Sorrell, JL Platt
Molecular Medicine 1998
Platelet and Thrombin Activity Following Cardiac Catheterization Despite Treatment with Aspirin
Andreotti, Lefroy, Sciahbasi, Crake, Maseri, Marco, Davies
Journal of Thrombosis and Thrombolysis 1998
Endothelial-derived nitric oxide preserves anticoagulant heparan sulfate expression in cultured porcine aortic endothelial cells
M Irokawa, M Nishinaga, U Ikeda, Y Shinoda, M Suematsu, N Gouda, Y Ishimura, K Shimada
Atherosclerosis 1997
IMMUNOLOGY OF XENOTRANSPLANTATION
S Saadi, JL Platt
Life Sciences 1997
EVALUATION OF A NEW SCREENING ASSAY PROC® GLOBAL FOR IDENTIFICATION OF DEFECTS IN THE PROTEIN C/PROTEIN S ANTICOAGULANT PATHWAY
K Ruzicka, S Kapiotis, P Quehenberger, S Handler, I Pabinger-Fasching, C Mannhalter, B Jilma, W Speiser
Thrombosis Research 1997
Thrombophilia found in patients with Moyamoya disease
H Tsuda, S Hattori, S Tanabe, S Nishioka, T Matsushima, K Ikezaki, M Fukui, S Kinoshita, N Hamasaki
Clinical Neurology and Neurosurgery 1997
Soluble complement receptor type 1 and antithrombin-III combination therapy prolongs xenograft survival: The role of thrombin and prostacyclin in hyperacute rejection
I Fujiwara, H Nakajima, K Akioka, T Matsuda, T Oka
Transplantation Proceedings 1997
Intrinsic Anticoagulation: Protein C, Protein S, and Thrombomodulin
JL Hale, N Nathan, M D'Ambra
Seminars in cardiothoracic and vascular anesthesia 1997
Regulation of Tissue Factor Initiated Thrombin Generation by the Stoichiometric Inhibitors Tissue Factor Pathway Inhibitor, Antithrombin-III, and Heparin Cofactor-II
C Veer, KG Mann
The Journal of biological chemistry 1997
CUTANEOUS NECROTIZING VASCULITIS
T Lotti, C Comacchi, I Ghersetich
International Journal of Dermatology 1996
Anticoagulant pretreatment attenuates production of cytokine-induced neutrophil chemoattractant following ischemia-reperfusion of rat liver
N Hisama, Y Yamaguchi, K Okajima, M Uchiba, K Murakami, K Mori, S Yamada, M Ogawa
Digestive Diseases and Sciences 1996
Shedding of heparan sulfate proteoglycan by stimulated endothelial cells: Evidence for proteolysis of cell-surface molecules
NS Ihrcke, JL Platt
Journal of Cellular Physiology 1996
Hereditary Thrombophilic Disease Associated with Defects in the Protein C Anticoagulant System
RG Doig
Hematology 1996
Role of granulocyte elastase in the formation of hemorrhagic shock-induced gastric mucosal lesions in the rat:
S Kushimoto, K Okajima, H Okabe, BR Binder
Critical Care Medicine 1996
Coagulation for Blood Bankers
JR Stubbs
Clinics in Laboratory Medicine 1996
Acute Catabolic State
A Revhaug
1996
Pathogenesis and Prophylaxis of Postoperative Thromboembolic Disease in Urological Pelvic Surgery
AS Kibel, KR Loughlin
The Journal of Urology 1995
Thrombin Regulates Expression of Monocyte Chemoattractant Protein-1 in Vascular Smooth Muscle Cells
UO Wenzel, B Fouqueray, G Grandaliano, YS Kim, C Karamitsos, AJ Valente, HE Abboud
Circulation research 1995
Thrombosis and Fibrinolysis in Acute Myocardial Infarction
PR Eisenberg
Alcoholism, clinical and experimental research 1994
A Perspective on Xenograft Rejection and Accommodation1
JL Platt
Immunological Reviews 1994
The antithrombotic effect of human activated protein c on He-Ne laser-induced thrombosis in rat mesenteric microvessels
T Yamashita, A Matsuoka, A Funatsu, J Yamamoto
Thrombosis Research 1994
The vascular endothelium in septic shock
JR Bradley, D Wilks, D Rubenstein
Journal of Infection 1994
Electrical Injury in the Femoral Artery of Rabbits as a Model for Arterial Thrombosis: A Pilot Study
R Kornowski, M Glikson, D Ohad, N Varda-Bloom, A Battler
Angiology 1994
Structure of a nonadecapeptide of the fifth EGF domain of thrombomodulin complexed with thrombin
II Mathews, KP Padmanabhan, A Tulinsky, JE Sadler
Biochemistry 1994
Membrane-dependent reactions in blood coagulation: role of the vitamin K-dependent enzyme complexes
M Kalafatis, NA Swords, MD Rand, KG Mann
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 1994
Laboratory Diagnosis of Hemorrhagic and Thrombotic Disorders
K Kottke-Marchant
Hematology/Oncology Clinics of North America 1994
The rotating disc as a device to study the adhesive properties of endothelial cells under differential shear stresses
CP Reutelingsperger, RG Gool, V Heijnen, P Frederik, T Lindhout
Journal of Materials Science: Materials in Medicine 1994
Thrombin stimulates proliferation of cultured rat aortic smooth muscle cells by a proteolytically activated receptor
CA McNamara, IJ Sarembock, LW Gimple, JW 2nd, SR Coughlin, GK Owens
Journal of Clinical Investigation 1993
Homocysteine, a thrombogenic agent, suppresses anticoagulant heparan sulfate expression in cultured porcine aortic endothelial cells
M Nishinaga, T Ozawa, K Shimada
Journal of Clinical Investigation 1993
New biological concepts on coagulation inhibitors
N Sala, J Fontcuberta, ML Rutllant
Intensive Care Medicine 1993
Developmental expression of chicken antithrombin III is regulated by increased RNA abundance and intracellular processing
DL Amrani, J Rosenberg, F Samad, G Bergtrom, DK Banfield
Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression 1993
Glycosaminoglycans exposed on the endothelial cell surface
S Cavari, S Vannucchi
FEBS Letters 1993
Protein S degradation in vitro by neutrophil elastase
I Eckle, R Seitz, R Egbring, G Kolb, K Havemann
Scandinavian Journal of Clinical & Laboratory Investigation 1993
Fibrinogenolytic and fibrinolytic activity of cell-associated plasmin
JE Humphries, J Vasudevan, SL Gonias
Arteriosclerosis Thrombosis and Vascular Biology 1993
Pathophysiology of Shock, Sepsis, and Organ Failure
G Schlag, H Redl
1993
Complex-dependent inhibition of factor VIIa by antithrombin III and heparin
JH Lawson, S Butenas, N Ribarik, KG Mann
The Journal of biological chemistry 1993
Fetal Stem Vessel Endothelial Changes in Placentae From Normal and Abnormal Pregnancies
CA Labarrere, WP Faulk
American Journal of Reproductive Immunology 1992
Microvascular Perturbations in Human Allografts: Analogies in Preeclamptic Placentae
CA Labarrere, WP Faulk
American Journal of Reproductive Immunology 1992
Bénéfices et risques des concentrés d'antithrombine III
J Conard
Annales Françaises d’Anesthésie et de Réanimation 1992
Association of coagulation factors and inhibitors with carotid artery atherosclerosis early results of the Atherosclerosis Risk in Communities (ARIC) study
KK Wu, AR Folsom, G Heiss, CE Davis, MG Conlan, R Barnes
Annals of Epidemiology 1992
Pathophysiology of ischemia in patients with coronary artery disease
AP Selwyn, AC Yeung, TJ Ryan, K Raby, J Barry, P Ganz
Progress in Cardiovascular Diseases 1992
Mononuclear Phagocytes
R van Furth
1992
Recurrent renal vein thrombosis and renal failure associated with antithrombin-III deficiency
D Ellis
Pediatric Nephrology 1992
Heparin and Related Polysaccharides
DA Lane, I Björk, U Lindahl
1992
Fish Oil and Vascular Disease
RD Caterina, SD Kristensen, EB Schmidt
1992
Detection of endothelial cell-reactive immunoglobulin in patients with anti-phospholipid antibodies
KR McCrae, A DeMichele, P Samuels, D Roth, A Kuo, Q Meng, J Rauch, DB Cines
British Journal of Haematology 1991
Case 30-1991 : An 85-Year-Old Woman with Renal Failure, Neurologic Deterioration, and Seizures
RC Cabot, RE Scully, EJ Mark, WF McNeely, BU McNeely, DJ Kuter, L Ellman, RT McCluskey
New England Journal of Medicine 1991
Biology of the impaired endothelium
EG Nabel
The American Journal of Cardiology 1991
Possible role of vascular intima for generation of coagulant activity in patients undergoing coronary thrombolysis with recombinant tissue-type plasminogen activator. A randomized, placebo-controlled study
S Munkvad, J Gram, J Jespersen
Scandinavian Journal of Clinical & Laboratory Investigation 1991
Pulmonary Embolism in the Elderly
J Hirsh
Cardiology Clinics 1991
The microcirculation in coronary ischemia. Are native anticoagulant mechanisms a path to new therapies?
BC Berk
Circulation 1991
Protein C activation following coronary artery occlusion in the in situ porcine heart
TR Snow, MT Deal, DT Dickey, CT Esmon
Circulation 1991
Human recombinant interleukin-1?- and tumor necrosis factor ?-mediated suppression of heparin-like compounds on cultured porcine aortic endothelial cells
K Shimada, T Ozawa, M Kobayashi
Journal of Cellular Physiology 1990
Clinical and biochemical characterization of antithrombin III Franconville, a variant with Pro 41 Leu mutation
N Roux, G Chadeuf, P Molho-Sabatier, PF Plouin, M Aiach
British Journal of Haematology 1990
Antithrombin III plus low-dose heparin in prophylaxis of deep vein thrombosis after total hip and total knee replacement
CW Francis
Journal of Vascular Surgery 1990
Superficial thrombophlebitis I. Primary hypercoagulable states
CP Samlaska, WD James
Journal of the American Academy of Dermatology 1990
New Trends in Haemostasis
J Harenberg, DL Heene, G Stehle, G Schettler
1990
Important role of arginine 129 in heparin-binding site of antithrombin III. Identification of a novel mutation arginine 129 to glutamine
S Gandrille, M Aiach, DA Lane, D Vidaud, P Molho-Sabatier, R Caso, P de Moerloose, JN Fiessinger, E Clauser
The Journal of biological chemistry 1990
Microvascular endothelial cell heterogeneity: Interactions with leukocytes and tumor cells
PN Belloni, RJ Tressler
Cancer and Metastasis Reviews 1990
Antithrombin III activity (residual thrombin activity) in plasma from non-medicated or heparinized horses
BJ Darien, J Potempa, JN Moore, J Travis
Veterinary Research Communications 1989
Thrombosis research
GP Clagett
Journal of Vascular Surgery 1989
Effect of a heparan sulphate with high affinity for antithrombin III upon inactivation of thrombin and coagulation factor Xa
MF Scully, V Ellis, N Shah, V Kakkar
Biochemical Journal 1989
Congenital antithrombin III deficiency: insights into the pathogenesis of the hypercoagulable state and its management using markers of hemostatic system activation
KA Bauer, RD Rosenberg
The American Journal of Medicine 1989
Antithrombin inactivation by neutrophil elastase requires heparin
RE Jordan, RM Nelson, MS Kilpatrick, JO Newgren, PC Esmon, MA Fournel
The American Journal of Medicine 1989
Placental Fibrin
WP Faulk
American Journal of Reproductive Immunology 1989
Antiphospholipid Antibodies and Recurrent Pregnancy Loss
DA Triplett
American Journal of Reproductive Immunology 1989
Antiphospholipid Antibodies and Reproduction
DA Triplett, EN Harris
American Journal of Reproductive Immunology 1989
Role of Fats in Human Nutrition
A Beynen, M Katan
Role of Fats in Human Nutrition 1989
Mapping active sites of blood coagulation serine proteases—activated protein C and thrombin—on simple graphics models
K Toma, K Suzuki
Journal of Molecular Graphics 1989
Effects of an oral antidiabetic drug (gliclazide) on inhibition of coagulation and fibrinolysis studied in insulin-treated diabetic patients (type I)
J Gram, S Munkvad, A Kold, J Jespersen
Fibrinolysis 1989
Enzyme linked immunosorbent assay for measuring antithrombin III
P Edgar, I Jennings, P Harper
Journal of clinical pathology 1989
Heparin and Prostacyclin
M Camici, L Evangelisti
Angiology 1989
Inactivation of Human Antithrombin by Neutrophil Elastase
RE Jordan, RM Nelson, J Kilpatrick, JO Newgren, PC Esmon, MA Fournel
The Journal of biological chemistry 1989
Impairment of primary haemostasis by low molecular weight heparins in rats
A Borowska, D Lauri, A Maggi, E Dejana, G Gaetano, MB Donati, J Pangrazzi
British Journal of Haematology 1988
PROTEIN C DEFICIENCY AND PORTAL THROMBOSIS IN LIVER TRANSPLANTATION IN CHILDREN
PL Harper, RJ Luddington, RW Carrell, N Barnes, PF Edgar, MJ Seaman, AT Salt, K Rolles, RY Calne
The Lancet 1988
Enhanced thrombin generation and platelet binding on herpes simplex virus-infected endothelium
MR Visser, PB Tracy, GM Vercellotti, JL Goodman, JG White, HS Jacob
Proceedings of the National Academy of Sciences 1988
Evaluation of lupus anticoagulants: Antiphospholipid antibodies, endothelium associated immunoglobulin, endothelial prostacyclin secretion, and antigenic protein S levels
TS Walker, DA Triplett, N Javed, K Musgrave
Thrombosis Research 1988
Heparan sulphate with no affinity for antithrombin III and the control of haemostasis
MF Scully, V Ellis, VV Kakkar
FEBS Letters 1988
International Review of Experimental Pathology
P Hoedemaeker
International Review of Experimental Pathology 1988
An Overview of Hemostasis
GC Troy
Veterinary Clinics of North America Small Animal Practice 1988
Cytotoxin-producing Escherichia coli and the Hemolytic Uremic Syndrome
TG Cleary
Pediatric Clinics of North America 1988
Behavior of antithrombin III isoforms on immobilized heparins. Evidence that the isoforms bind to different numbers of low-affinity heparin sites
TH Carlson, T Babcock, AC Atencio, C Levinson, HR Mora
The Journal of biological chemistry 1988
Thrombogenic and Nonthromboge0nic Biological Surfaces
JF Mustard, HM Groves, RL Kinlough-Rathbone, MA Packham
Annals of the New York Academy of Sciences 1987
Vascular Endothelium: Nature's Blood-Compatible Container
MA Gimbrone
Annals of the New York Academy of Sciences 1987
An abnormal antithrombin III (AT III) with low heparin affinity: AT III Clichy
M Aiach, D Franclois, P Priollet, L Capron, M Roncato, M Alhenc-Gelas, JN Fiessinger
British Journal of Haematology 1987
Occurrence of blood coagulation factorsin situ in small cell carcinoma of the lung
LR Zacharski, VA Memoli, SM Rousseau, W Kisiel
Cancer 1987
The inhibition of thrombin-dependent positive-feedback reactions is critical to the expression of the anticoagulant effect of heparin
FA Ofosu, P Sie, GJ Modi, F Fernandez, MR Buchanan, MA Blajchman, B Boneu, J Hirsh
Biochemical Journal 1987
Protein C deficiency in splanchnic venous thrombosis
D Green, DR Ganger, AT Blei
The American Journal of Medicine 1987
The regulation of natural anticoagulant pathways
C Esmon
Science 1987
Immune Endothelial-Cell Injury in Heparin-Associated Thrombocytopenia
DB Cines, A Tomaski, S Tannenbaum
New England Journal of Medicine 1987
The New Dimensions of Warfarin Prophylaxis
S Wessler, CG Becker, Y Nemerson
1987
Heparin Promotes the Inactivation of Antithrombin by Neutrophil Elastase
RE Jordan, J Kilpatrick, RM Nelson
Science 1987
Activation of endogenous factor V by a homocysteine-induced vascular endothelial cell activator
GM Rodgers, WH Kane
Journal of Clinical Investigation 1986
Novel Immunoenzyme Assays for Thrombin-Antithrombin III and Thrombin-?2-Macroglobulin Complexes in Plasma
PC Harpel, JW Fenton
Annals of the New York Academy of Sciences 1986
Endothelial binding sites for heparin. Specificity and role in heparin neutralization
T Bârzu, JL van Rijn, M Petitou, P Molho, G Tobelem, JP Caen
Biochemical Journal 1986
Activation of coagulation releases endothelial cell mitogens
C Gajdusek, S Carbon, R Ross, P Nawroth, D Stern
The Journal of Cell Biology 1986
Modulation of endothelial cell hemostatic properties by tumor necrosis factor
PP Nawroth, DM Stern
Journal of Experimental Medicine 1986
Plasmalemmal proteins of cultured vascular endothelial cells exhibit apical-basal polarity: analysis by surface-selective iodination
WA Muller, MA Gimbrone
The Journal of Cell Biology 1986
Heparin cofactor activity and antithrombin iii antigen levels in preeclampsia
KD Friedman, Z Borok, J Owen
Thrombosis Research 1986
Novel Immunoenzyme Assays for Thrombin-Antithrombin III and Thrombin-? 2 -Macroglobulin Complexes in Plasma
PC Harpel, JW Fenton
Annals of the New York Academy of Sciences 1986
Clinical Efficacy of Heparin Fractions: Issues and Answers
HL Messmore, J Hirsh
Critical Reviews in Clinical Laboratory Sciences 1986
New Insights into Hypercoagulable States
RD Rosenberg, KA Bauer
Hospital Practice 1986
Coagulation, Inflammation, and Responses to Injury
E Pottmeyer, MJ Vassar, JW Holcroft
Critical Care Clinics 1986
Fibrinogen ? proteolysis in acute myelogenous leukemia (AML)
T Eckhardt, M Koch
Blut Zeitschrift für die Gesamte Blutforschung 1986
Endothelial cell reactions with heparin
T Bârzu, JL Rijn, J Rosenbaum, G Tobelem
The Medical Journal of Australia 1986
Formation of meizothrombin as intermediate in factor Xa-catalyzed prothrombin activation
J Rosing, RF Zwaal, G Tans
The Journal of biological chemistry 1986
Isolation and partial purification of a novel anticoagulant from arteries of human umbilical cord
CP REUTELINGSPERGER, G HORNSTRA, HC HEMKER
European Journal of Biochemistry 1985
Release of heparan sulfate proteoglycans from cultured aortic endothelial cells by thrombin
K Shimada, T Ozawa
Thrombosis Research 1985
The Use of Antithrombotic Therapy in the Elderly
T Smith, F Viverette, B Adelman
Clinics in Geriatric Medicine 1985
Formation of the Fibrin Clot: the Balance of Procoagulant and Inhibitory Factors
B Lämmle, JH Griffin
Clinics in Haematology 1985

← Previous 1 2 3 … 7 8 Next →

Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts

Referenced in 1 patents
58 readers on Mendeley
See more details